Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's Disease

Sushil K. Garg, Fernando S. Velayos, John B. Kisiel

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Crohn's disease (CD) is a chronic inflammatory disease that confers a higher risk of cancer than in the general population. New, large, population-based studies in the past decade show that patients with CD are at higher risk of colorectal, small bowel, melanoma, and cervical cancer. Patients who use thiopurines are at additional risk of development of lymphoma and nonmelanoma skin cancer. Preventive surveillance for cancers of the colorectum, skin, and uterine cervix is advised.

Original languageEnglish (US)
Pages (from-to)515-529
Number of pages15
JournalGastroenterology Clinics of North America
Issue number3
StatePublished - Sep 2017


  • 6-mercaptopurine/adverse effects
  • Colorectal neoplasms
  • Inflammatory bowel diseases
  • Lymphoma
  • Monoclonal antibodies/adverse effects
  • Skin neoplasms/secondary

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Intestinal and Nonintestinal Cancer Risks for Patients with Crohn's Disease'. Together they form a unique fingerprint.

Cite this